Biotech entity
pharma accounts for 3 of the 5 tracked stories, while 2 other categories carry the remainder. Against the same-window beat baseline of 17% negative, this entity's 0% share is less negative. Source depth averages 2.4 original sources per story, versus 3.6 across the same-window beat baseline.
Last mentioned: Aug 7, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 60 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma accounts for 3 of the 5 tracked stories, while 2 other categories carry the remainder. Against the same-window beat baseline of 17% negative, this entity's 0% share is less negative. Source depth averages 2.4 original sources per story, versus 3.6 across the same-window beat baseline. The 170-day window averages about 0.2 stories each week. The 6.4 average consequence score is above the beat benchmark of 6.2 in the same window. AI is the most frequent co-covered peer, appearing in 1 of the 5 tracked stories. Mayo Clinic appears in 5 tracked Biotech stories published from February 19, 2026 through August 7, 2026.
Computed from the 5 stories linked to this entity, with beat comparisons drawn from all 688 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Mayo Clinic. Shared-story counts are live from our verified record — not editorial picks.
First in-orbit medical X-ray
A crewmember aboard a commercial spaceflight captures a diagnostic hand radiograph on day L+1, confirming that diagnostic imaging is possible in sustained orbital microgravity.
Clinical Milestones
Anticipated updates on Phase 1/2 trial progress for MT-125 in GBM.
BioFlorida Showcase
Presentation in the Cornerstone Session: Innovation at BioFlorida.
Investival Showcase
Participation in the South Florida - The Rising Life Science Hub event.
Conference Announcement
Invited to present at two major South Florida life sciences events.
Partnering Circuit
Presented at BioCom California Global Life Science Partnering Conference.
Parabolic flight test
Dr. Gifford's team successfully obtains a digital X-ray of a hand in microgravity during a parabolic flight, proving the feasibility of portable X-ray in weightlessness.
The devastating speed of Chris Johnson’s sporadic ALS—from an elite athlete to eye-controlled communication in a year—exposes the profound unmet need in neurodegenerative drug development. With current therapies offering only months of survival benefit, the biopharma sector faces immense pressure to deliver disease-modifying treatments.
Source: abcnews.com · thegrio.com
The first medical X-ray in space was captured with a compact, battery-powered digital radiography unit, validating a new wave of devices that minimize radiation while delivering diagnostic images. Biotech investors and device manufacturers are eyeing dual-use applications in telehealth and expedition medicine.
Source: hometownregister.com · wyomingnews.com
Cognivia and Mayo Clinic are zeroing in on non-adherence, missed appointments, and trial dropout—three behavioral factors that inflate clinical trial costs and delay drug development. By making patient behavior measurable, the partnership could help biopharma sponsors de-risk studies and improve real-world evidence.
Source: prnewswire.com · prnewswire.com
Myosin Therapeutics is set to present its first-in-class NMIIA/IIB inhibitor, MT-125, at two major South Florida life sciences conferences this March. The company's unique approach targets the physical mechanics of glioblastoma cells, offering a potential solution to traditional drug resistance.
Merck and Mayo Clinic have entered a multi-year research and development collaboration to leverage artificial intelligence for drug discovery and personalized patient care. The partnership integrates Merck's pharmaceutical expertise with Mayo Clinic's clinical data and AI capabilities to accelerate the development of targeted therapies.
Source: Yahoo Finance · Mayo Clinic News Network
Mayo Clinic is linked from 5 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
